Global Research
New Study In Journal Of Public Health Finds Autism And Cancer Related To Human Fetal DNA In VaccinesUsing statistical analysis and data from the US Government, UK, Denmark and Western Australia, scientists at Sound Choice Pharmaceutical Institute (SCPI) found that increases in autistic disorder correspond with the introduction of vaccines using human fetal cell lines and retroviral contaminants.
Even more alarming, Dr Theresa Deisher, lead scientist and SCPI founder noted that, “Not only are the human fetal contaminated vaccines associated with autistic disorder throughout the world, but also with epidemic childhood leukemia and lymphomas.”
Their study comes on the heels of recent breaking news that the CDC deliberately withheld evidence of the significant increase in autism among African-American boys who were vaccinated prior to 36 months of age. (See: http://www.examiner.com/article/whistleblower-reveals-cdc-cover-up-linking-mmr-vaccine-to-autism).
So it should come as no surprise that the FDA has known for decades about the dangers of insertional mutagenesis by using the human fetal cell lines and yet, they chose to ignore it. Instead of conducting safety studies they regulated the amount of human DNA that could be present in a vaccine to no greater than 10ng. (www.fda.gov/ohrms/dockets/ac/05/slides/5-4188S1_4draft.ppt)
Unfortunately, Dr. Deisher’s team discovered that the fetal DNA levels ranged anywhere from 142ng – 2000ng per dose, way beyond the so-called “safe” level.
“There are a large number of publications about the presence of HERV (human endogenous retrovirus – the only re-activatable endogenous retrovirus) and its association with childhood lymphoma,” noted Dr Deisher. “The MMR II and chickenpox vaccines and indeed all vaccines that were propagated or manufactured using the fetal cell line WI-38 are contaminated with this retrovirus. And both parents and physicians have a right to know this!”
Certainly these discoveries by SCPI should generate an immediate investigation by FDA officials, if not an outright ban on the use of aborted fetal cell lines as substrates for vaccine production. There are numerous other non-human FDA-approved cell lines that can and should be used.
Dr Deisher’s study is available on the Academic Journals website at:
http://www.ms.academicjournals.org/article/article1409245960_Deisher%20et%20al.pdf
or on their website at www.soundchoice.org/scpiJournalPubHealthEpidem092014.pdf
Dr. Theresa Deisher is a PhD in Molecular and Cellular Physiology from Stanford University with over 20 years in commercial biotechnology, prior to founding AVM Biotechnology and Sound Choice Pharmaceutical Institute. As an inventor of 23 issued US patents she is world-renowned for her work in adult stem cell research and the first to discover adult cardiac derived stem cells. Dr. Deisher was a plaintiff in the US federal lawsuit to prohibit the use of taxpayer dollars for embryo destructive research, which resulted in steering science towards adult stem cell research and 14 US FDA approved adult stem cell products.
Disclaimer: The contents of this article are of sole
responsibility of the author(s). The Centre for Research on
Globalization will not be responsible for any inaccurate or incorrect
statement in this article. The Center of Research on Globalization
grants permission to cross-post original Global Research articles on
community internet sites as long as the text & title are not
modified. The source and the author's copyright must be displayed. For
publication of Global Research articles in print or other forms
including commercial internet sites, contact: publications@globalresearch.ca
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.
For media inquiries: publications@globalresearch.ca
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.
For media inquiries: publications@globalresearch.ca
Copyright © Global Research News, Sound Choice Pharmaceutical Institute, 2014
No comments:
Post a Comment